NCT03634982 2022-09-01Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Unknown133 enrolled
NCT04371796 2020-05-01Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLCSichuan Cancer Hospital and Research InstitutePhase 2 Unknown20 enrolled
NCT04133337 2019-10-21Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLCSichuan Cancer Hospital and Research InstitutePhase 1/2 Unknown20 enrolled
NCT03389256 2018-01-03Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLCSichuan Cancer Hospital and Research InstitutePhase 2 Unknown144 enrolled